FDA Import Refusal 1FX-1301431-1/10002/7 — Intas Pharmaceuticals Limited
The FDA refused shipment 1FX-1301431-1/10002/7 from Intas Pharmaceuticals Limited (India) on Aug 3, 2026. The refused product falls under Drugs and Biologics — MONTELUKAST SODIUM (ANTI-ASTHMATIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 3, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61EAA09 MONTELUKAST SODIUM (ANTI-ASTHMATIC)
- Charges
- 118,75